Hudson Bay Capital Management
ELV icon

Hudson Bay Capital Management’s Elevance Health ELV Stock Holding History

Hudson Bay Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800
Closed -$311K – 1372
2025
Q2 		$311K Buy
+800
New +$322K ﹤0.01% 1163
2019
Q1 		– Sell
-31,500
Closed -$8.27M – 754
2018
Q4 		$8.27M Hold
31,500
– – 0.11% 170
2018
Q3 		$8.63M Buy
+31,500
New +$8.18M 0.11% 171

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Hudson Bay Capital Management's ELV Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 821 shares — an estimated $265K sold.

Hudson Bay Capital Management first reported a position in ELV in Q2 2015 and held it in 14 quarters. The position peaked at $61M in Q2 2018. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 821 Elevance Health shares in Q4 2025, an estimated $265K.
  • Hudson Bay Capital Management first reported a position in Elevance Health in Q2 2015 and held it in 14 quarters.
  • Hudson Bay Capital Management's Elevance Health position peaked at $61M in Q2 2018.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.